MONITORING OF CHIMERISM IN PATIENTS WITH ACUTE MYELOID LEUKEMIA AFTER HEMATOPOIETIC STEM CELL TRANSPLANTATION BY QUANTITATIVE ASSESSMENT: THE BEST TOOL FOR MONITORING OF MINIMAL RESIDUAL DISEASE?

被引：0
|
作者：
Bouvier, A. [1 ]
Thepot, S. [2 ]
Francois, S. [2 ]
Guardiola, P. [3 ]
Tanguy-Schmidt, A. [2 ]
Beucher, A. [1 ]
Genevieve, F. [1 ]
Hunault-Berger, M. [2 ]
Zandecki, M. [1 ]
Ifrah, N. [2 ]
Blanchet, O. [1 ]
机构：
[1] CHU Angers, Hematol Lab, Angers, France
[2] CHU Angers, Serv Malad Sang, Angers, France
[3] CHU Angers, Plateforme STE, Angers, France
来源：
HAEMATOLOGICA | 2014年 / 99卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
PB1417
引用
收藏
页码：553 / 554
页数：2
相关论文
共 50 条
  • [21] Minimal residual disease analysis by flow cytometry patients with acute myeloid leukemia before and after allogeneic hematopoietic stem cell transplantation
    Kozanoglu, I.
    Unver, G.
    Yeral, M.
    Gereklioglu, C.
    Korur, A. P.
    Buyukkurt, N.
    Solmaz, S.
    Kasar, M.
    Boga, C.
    Ozdogu, H.
    BONE MARROW TRANSPLANTATION, 2015, 50 : S241 - S242
  • [22] Minimal Residual Disease Analysis by Flow Cytometry in Patients with Acute Myeloid Leukemia Before and After Allogeneic Hematopoietic Stem Cell Transplantation
    Georgieva, Y.
    Michova, A.
    Ganeva, P.
    Petrov, Y.
    Spassov, B.
    Balatzenko, G.
    Arnaudov, G.
    Mihaylov, G.
    Guenova, M.
    BONE MARROW TRANSPLANTATION, 2016, 51 : S286 - S287
  • [23] Kinetics of minimal residual disease and chimerism in patients with chronic myeloid leukemia after nonmyeloablative conditioning and allogeneic stem cell transplantation
    Uzunel, M
    Mattsson, J
    Brune, M
    Johansson, JE
    Aschan, J
    Ringdén, O
    BLOOD, 2003, 101 (02) : 469 - 472
  • [24] Molecular-genetic monitoring of haematopoietic chimerism and minimal residual disease in AML patients after stem cell transplantation
    Blau, O.
    Gentilini, C.
    Nogai, A.
    Reinwald, M.
    Sindram, A.
    Thiel, E.
    Uharek, L.
    Blau, I. W.
    BONE MARROW TRANSPLANTATION, 2008, 41 : S334 - S335
  • [25] Prognostic Value of Minimal Residual Disease before Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Acute Myeloid Leukemia
    Perez-Lopez, Olga
    Caballero-Velazquez, Teresa
    Colado, Enrique
    Alonso, Sara
    Gonzalez-Campos, Jose
    Prats-Martin, Concepcion
    Rodriguez-Torres, Nancy
    Escamilla Gomez, Virginia
    Espigado, Ildefonso
    Antonio Perez-Simon, Jose
    BLOOD, 2018, 132
  • [26] CD34+chimerism analysis for minimal residual disease monitoring after allogeneic hematopoietic cell transplantation
    Unnikrishnan, Athira
    Meacham, Amy M.
    Goldstein, Steven S.
    Ta, Mai
    Leather, Helen L.
    Cogle, Christopher R.
    Castillo, Paul
    Wingard, John R.
    Norkin, Maxim
    LEUKEMIA RESEARCH, 2018, 74 : 110 - 112
  • [27] Monitoring Measurable Residual/Relapsing Disease after Allogeneic Hematopoietic Stem Cell Transplantation in Adult Patients with Acute Lymphoblastic Leukemia
    Wethmar, K.
    Matern, S.
    Esseling, E.
    Bruggemann, M.
    Schliemann, C.
    Berdel, W. E.
    Lenz, G.
    Stelljes, M.
    ANNALS OF HEMATOLOGY, 2019, 98 : S57 - S57
  • [28] Combined usage of Wilms' tumor gene quantitative analysis and multiparameter flow cytometry for minimal residual disease monitoring of acute myeloid leukemia patients after allogeneic hematopoietic stem cells transplantation
    Hao, Yingchan
    Cheng, Yanhong
    Wu, Quan
    Zhang, Aimei
    Jiang, Xiaoxiao
    Xu, Xiucai
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2018, 15 (02) : 1403 - 1409
  • [29] Quantitative monitoring of WT1 expression in peripheral blood before and after allogeneic stem cell transplantation for acute myeloid leukemia - a useful tool for early detection of minimal residual disease
    Polak, J.
    Valkova, V.
    Vitek, A.
    Hajkova, H.
    Markova, M.
    Salek, C.
    Cetkovsky, P.
    TISSUE ANTIGENS, 2011, 77 (05): : 415 - 415
  • [30] Quantitative monitoring of WT1 expression in peripheral blood before and after allogeneic stem cell transplantation for acute myeloid leukemia - a useful tool for early detection of minimal residual disease
    Polak, J.
    Hajkova, H.
    Haskovec, C.
    Cechova, H.
    Marinov, I.
    Mikulenkova, D.
    Markova, J.
    Markova, M.
    Vitek, A.
    Valkova, V.
    NEOPLASMA, 2013, 60 (01) : 74 - 82
12345